| Literature DB >> 34580976 |
Yue-Gui Chen1,2,3, De-Sen Li1,2,3, Yi Ling2, Yan-Chun Liu2,3, Zhi-Li Zuo2, Li-She Gan4, Shi-Hong Luo2, Juan Hua2, Ding-Yuan Chen2, Fan Xu4, Man Li2,3, Kai Guo1, Yan Liu1,2, Jonathan Gershenzon5, Sheng-Hong Li1,2.
Abstract
A versatile terpene synthase (LcTPS2) producing unconventional macrocyclic terpenoids was characterized from Leucosceptrum canum. Engineered Escherichia coli and Nicotiana benthamiana expressing LcTPS2 produced six 18-/14-membered sesterterpenoids including five new ones and two 14-membered diterpenoids. These products represent the first macrocyclic sesterterpenoids from plants and the largest sesterterpenoid ring system identified to date. Two variants F516A and F516G producing approximately 3.3- and 2.5-fold, respectively, more sesterterpenoids than the wild-type enzyme were engineered. Both 18- and 14-membered ring sesterterpenoids displayed significant inhibitory activity on the IL-2 and IFN-γ production of T cells probably via inhibition of the MAPK pathway. The findings will contribute to the development of efficient biocatalysts to create bioactive macrocyclic sesterterpenoids, and also herald a new potential in the well-trodden territory of plant terpenoid biosynthesis.Entities:
Keywords: Leucosceptrum canum; enzyme engineering; immunosuppressive activity; macrocyclic terpenoids; sesterterpene synthase
Mesh:
Substances:
Year: 2021 PMID: 34580976 DOI: 10.1002/anie.202110842
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336